MK-0482

· Presage Biosciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK-0482, covering 2024-05-14 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) [Phase 1]

See pricing